Namita Sood, M.D., F.C.C.P.

Namita Sood, M.D., F.C.C.P.

Specialties

Lung Disease

Pulmonary Medicine

Vascular Medicine

Department

Internal Medicine

Reviews

To see if Namita Sood is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Medical Group - Sacramento (J Street)

2825 J St., Suite 400
Sacramento, CA 95816
Driving Directions

Primary Phone:
916-734-8230

Additional Phone Numbers

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Philosophy of Care

I believe that it is a privilege to be a physician. I work every day to provide the best medical advice to my ability and develop treatment plan with the patient based on their goals and expectations.

Clinical Interests

Dr Sood is a Pulmonary, Critical care specialist offering care for patients with advanced lung disease. She has special interest and expertise in Pulmonary vascular Disease including pulmonary hypertension, pulmonary embolism, lung disease related to Rheumatological disease and sickle cell anemia.

Research/Academic Interests

Dr. Sood’s research interest focuses on new treatments for pulmonary hypertension.

Division

Pulmonary, Critical Care, and Sleep Medicine

Center/Program Affiliation

UC Davis Medical Group

Education

M.B.B.Ch., Al Fateh University, Tripoli, Libya 1988

Internship: Internal Medicine, University of Missouri - Columbia, Columbia MO 1992-1993

Residency

Internal Medicine, University of Missouri - Columbia, Columbia MO 1993-1995

Fellowships

Pulmonary/Critical Care, University of North Carolina, Chapel Hill NC 1996-1999

Board Certifications

American Board of Internal Medicine,

American Board of Internal Medicine, Critical Care Medicine,

American Board of Internal Medicine, Pulmonary Medicine,

Professional Memberships

American College of Chest Physicians - Fellow

American Thoracic Society

Pulmonary Hypertension Association

Pulmonary Vascular Institute - Fellow

Honors and Awards

Distinguished Chest Educator of the American College of Chest Physician, 2019

Best Doctors in America, 2005, 2007, 2009, 2011, 2013, 2015, 2017

Best Physicians in America, 2016

Excellence in Teaching, Ohio state University, 2016

Select Recent Publications

Torres F, Farber H, Ristic A, McLaughlin V, Adams J, Zhang J, Klassen P, Shanahan W, Grundy J, Hoffmann I Escribano Subías PE, Sood N, Keogh A, D’Souza G, Rubin L. Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy Results from a Phase 2 randomized, parallel group, placebo-controlled trial. Eur Respir J. 2019 Oct 10;54(4).

Sood N, Aranda A, Platt D, LaRose A, Kleinjung F, O’Brien G, (are there more authors?)  Riociguat improves health-related quality of life for patients with pulmonary arterial hypertension: results from the phase 4 MOTION study. Pulm Circ. 2019 Jan-Mar;9(1).

Bartolome S, Sood N, Shah T, Styrvoky K, Torres F, Chin K. Mortality in Patients With Pulmonary Arterial Hypertension Treated With Continuous Prostanoids. Chest. 2018 Sep;154(3):532-540.

Von Visger TT, Kuntz KK, Phillips GS, Yildiz VO, Sood N. Quality of Life and Physiological Symptoms in Patients with Pulmonary Hypertension. Heart & Lung. 2018 January 24.

Hill NS, Rahaghi FF, Sood N, Frey R, Ghofrani H. Individual Dose Adjustment of Riociguat in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. Respiratory Medication. 2017 August;129:124-129.

Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch J, Wells P, Woller SC, Moores L. Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report. Chest. 2016 February;149(2):315-3.

Taichman D, Ornelas J, Chung L, Klinger J, Lewis SZ, Mandel J, Palevsky H, Stuart R, Sood N, Trow T, Yung REC, Badesch D. Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults CHEST Guidelines. Chest. 2014 August.

Klings ES, Machado RF, Barst RJ, Sood N et al. An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease. American Journal of Respiratory and Critical Care Medicine. 2014 March;189(6):727-740.

Sood N. Managing an Acutely Ill Patient with Pulmonary Arterial Hypertension. Expert Review of Respiratory Medicine. 2013 February;7(1):77-83.

Moseley MG, Crestanello JA, Sood N. Massive Pulmonary Embolism Algorithm. Journal of Emergency Medicine. 2008 June.